Krasimir A. Spasov

2.2k citations

36 papers · 1.7k indexed · h-index 21

Co-authors: Karen S. Anderson William L. Jorgensen Vinzenz M. Unger Mariela Bollini Pietro De Camilli Rushika M. Perera Aurélien Roux Olivier Destaing
Topics: HIV/AIDS drug development and treatment (24 papers)HIV Research and Treatment (20 papers)Pneumocystis jirovecii pneumonia detection and treatment (9 papers)
Cited by: Virology Infectious Diseases Cell Biology
Journals: Cell Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United States Canada Taiwan

In The Last Decade

Krasimir A. Spasov

35 papers receiving 1.7k citations

Peers

Countries citing papers authored by Krasimir A. Spasov

Since Specialization

Citations

This map shows the geographic impact of Krasimir A. Spasov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krasimir A. Spasov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krasimir A. Spasov more than expected).

Fields of papers citing papers by Krasimir A. Spasov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krasimir A. Spasov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krasimir A. Spasov. The network helps show where Krasimir A. Spasov may publish in the future.

Co-authorship network of co-authors of Krasimir A. Spasov

This figure shows the co-authorship network connecting the top 25 collaborators of Krasimir A. Spasov. A scholar is included among the top collaborators of Krasimir A. Spasov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krasimir A. Spasov. Krasimir A. Spasov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design, synthesis, and biological testing of biphenylmethyloxazole inhibitors targeting HIV-1 reverse transcriptase 2023 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Krasimir A. Spasov,Karen S. Anderson,William L. Jorgensen	3
2	Exploring novel HIV‐1 reverse transcriptase inhibitors with drug‐resistant mutants: A double mutant surprise 2023 ·Protein Science ·(unknown),Albert H. Chan,Kathleen M. Frey,(unknown),Joseph A. Ippolito,Krasimir A. Spasov,Yang-Hui Jimmy Yeh,William L. Jorgensen,Ya‐Chi Ho,Karen S. Anderson	2
3	Covalent and noncovalent strategies for targeting Lys102 in HIV-1 reverse transcriptase 2023 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),(unknown),Krasimir A. Spasov,William L. Jorgensen,Karen S. Anderson	3
4	Structural Studies and Structure Activity Relationships for Novel Computationally Designed Non-nucleoside Inhibitors and Their Interactions With HIV-1 Reverse Transcriptase 2022 ·Frontiers in Molecular Biosciences ·Kathleen M. Frey,(unknown),Albert H. Chan,Joseph A. Ippolito,Mariela Bollini,Krasimir A. Spasov,William L. Jorgensen,Karen S. Anderson	8
5	Covalent Inhibition of Wild-Type HIV-1 Reverse Transcriptase Using a Fluorosulfate Warhead 2021 ·ACS Medicinal Chemistry Letters ·Joseph A. Ippolito,(unknown),(unknown),(unknown),(unknown),Krasimir A. Spasov,José A. Cisneros,(unknown),Kara J. Cutrona,Karen S. Anderson,William L. Jorgensen	20
6	Long‐acting and extended‐release implant and nanoformulations with a synergistic antiretroviral two‐drug combination controls HIV‐1 infection in a humanized mouse model 2021 ·Bioengineering & Translational Medicine ·Jagadish Beloor,Shalley N. Kudalkar,(unknown),Fan Yang,Hanna K. Mandl,(unknown),Krasimir A. Spasov,William L. Jorgensen,W. Mark Saltzman,Karen S. Anderson,Priti Kumar	9
7	Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency 2021 ·ACS Medicinal Chemistry Letters ·(unknown),Krasimir A. Spasov,(unknown),(unknown),Elizabeth A. Stone,Joseph A. Ippolito,(unknown),M.G. Deshmukh,Julian Tirado‐Rives,Shuo Zhang,Zhuobin Liang,Scott J. Miller,Farren J. Isaacs,Brett D. Lindenbach,Karen S. Anderson,William L. Jorgensen	41
8	Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations 2021 ·ACS Central Science ·Chunhui Zhang,Elizabeth A. Stone,M.G. Deshmukh,Joseph A. Ippolito,Mohammad Mehdi Ghahremanpour,Julian Tirado‐Rives,Krasimir A. Spasov,Shuo Zhang,(unknown),Shalley N. Kudalkar,Zhuobin Liang,Farren J. Isaacs,Brett D. Lindenbach,Scott J. Miller,Karen S. Anderson,William L. Jorgensen	178
9	Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine Resistance 2015 ·ACS Medicinal Chemistry Letters ·(unknown),Kathleen M. Frey,Sarah B. Laskey,(unknown),Krasimir A. Spasov,(unknown),Mariela Bollini,Robert F. Siliciano,William L. Jorgensen,Karen S. Anderson	23
10	Discovery and crystallography of bicyclic arylaminoazines as potent inhibitors of HIV-1 reverse transcriptase 2015 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Kathleen M. Frey,Ricardo Gallardo‐Macias,Krasimir A. Spasov,Albert H. Chan,Karen S. Anderson,William L. Jorgensen	18
11	Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants 2015 ·Journal of Medicinal Chemistry ·Kathleen M. Frey,(unknown),Krasimir A. Spasov,(unknown),William L. Jorgensen,Karen S. Anderson	41
12	DEAD-Box RNA Helicase Dbp4 Is Required for Small-Subunit Processome Formation and Function 2014 ·Molecular and Cellular Biology ·Sahar Soltanieh,Yvonne N. Osheim,Krasimir A. Spasov,Christian Trahan,Ann L. Beyer,François Dragon	16
13	Extension into the entrance channel of HIV-1 reverse transcriptase—Crystallography and enhanced solubility 2013 ·Bioorganic & Medicinal Chemistry Letters ·Mariela Bollini,Kathleen M. Frey,José A. Cisneros,Krasimir A. Spasov,Kalyan Das,Joseph D. Bauman,Eddy Arnold,Karen S. Anderson,William L. Jorgensen	33
14	Discovery of dimeric inhibitors by extension into the entrance channel of HIV-1 reverse transcriptase 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Mariela Bollini,Robert A. Domaoal,Krasimir A. Spasov,Karen S. Anderson,William L. Jorgensen	25
15	Quasi-biomimetic ring contraction promoted by a cysteine-based nucleophile: Total synthesis of Sch-642305, some analogs and their putative anti-HIV activities 2011 ·Chemical Science ·Alpay Dermenci,Philipp Selig,Robert A. Domaoal,Krasimir A. Spasov,Karen S. Anderson,Scott J. Miller	51
16	Structural Basis of Membrane Invagination by F-BAR Domains 2008 ·Cell ·Adam Frost,Rushika M. Perera,Aurélien Roux,Krasimir A. Spasov,Olivier Destaing,Edward H. Egelman,Pietro De Camilli,Vinzenz M. Unger	442
17	RAC protein induces enzymatic access to the maturing 3′-end of the 25S rRNA in Schizosaccharomyces pombe 2008 ·Biochemical and Biophysical Research Communications ·Krasimir A. Spasov,Ross N. Nazar	0
18	Characterization of a Novel Prokaryotic GDP Dissociation Inhibitor Domain from the G Protein Coupled Membrane Protein FeoB 2007 ·Journal of Molecular Biology ·Edward T. Eng,Amir Reza Jalilian,Krasimir A. Spasov,Vinzenz M. Unger	36
19	Pre-18S Ribosomal RNA Is Structurally Compacted into the SSU Processome Prior to Being Cleaved from Nascent Transcripts in Saccharomyces cerevisiae 2004 ·Molecular Cell ·Yvonne N. Osheim,Sarah L. French,(unknown),(unknown),Krasimir A. Spasov,François Dragon,Susan J. Baserga,Ann L. Beyer	218
20	RAC Protein Directs the Complete Removal of the 3′ External Transcribed Spacer by the Pac1 Nuclease 2002 ·Molecular Cell ·Krasimir A. Spasov,(unknown),(unknown),Ross N. Nazar	14

About Krasimir A. Spasov

Krasimir A. Spasov is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 36 papers that have together received 1.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (24 papers), HIV Research and Treatment (20 papers) and Pneumocystis jirovecii pneumonia detection and treatment (9 papers). The work is most often cited by research in Virology (321 citations), Infectious Diseases (510 citations) and Cell Biology (352 citations). Krasimir A. Spasov has collaborated with scholars based in United States, Canada and Taiwan. Frequent co-authors include Karen S. Anderson, William L. Jorgensen, Vinzenz M. Unger, Mariela Bollini, Pietro De Camilli, Rushika M. Perera, Aurélien Roux, Olivier Destaing, Edward H. Egelman and Adam Frost. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact